These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16256354)

  • 1. Classification of dopamine antagonists using functional feature hypothesis and topological descriptors.
    Kim HJ; Cho YS; Koh HY; Kong JY; No KT; Pae AN
    Bioorg Med Chem; 2006 Mar; 14(5):1454-61. PubMed ID: 16256354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of dopamine, serotonin, and dual antagonists by decision trees.
    Kim HJ; Choo H; Cho YS; Koh HY; No KT; Pae AN
    Bioorg Med Chem; 2006 Apr; 14(8):2763-70. PubMed ID: 16387502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of dopamine antagonists using TFS-based artificial neural network.
    Fujishima S; Takahashi Y
    J Chem Inf Comput Sci; 2004; 44(3):1006-9. PubMed ID: 15154769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
    Oloff S; Mailman RB; Tropsha A
    J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.
    Hoffman BT; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2000 Nov; 43(22):4151-9. PubMed ID: 11063611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved 3D-QSAR CoMFA of the dopamine transporter blockers with multiple conformations using the genetic algorithm.
    Yuan H; Petukhov PA
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6267-72. PubMed ID: 17027270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.
    Wei J; Wang S; Gao S; Dai X; Gao Q
    J Chem Inf Model; 2007; 47(2):613-25. PubMed ID: 17330954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
    Krovat EM; Langer T
    J Med Chem; 2003 Feb; 46(5):716-26. PubMed ID: 12593652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical function based pharmacophore generation of endothelin-A selective receptor antagonists.
    Funk OF; Kettmann V; Drimal J; Langer T
    J Med Chem; 2004 May; 47(11):2750-60. PubMed ID: 15139753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of biological targets using probabilistic neural networks and atom-type descriptors.
    Niwa T
    J Med Chem; 2004 May; 47(10):2645-50. PubMed ID: 15115405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling of cyclin-dependent kinase inhibition by 1H-pyrazolo[3,4-d]pyrimidine derivatives using artificial neural network ensembles.
    Fernández M; Tundidor-Camba A; Caballero J
    J Chem Inf Model; 2005; 45(6):1884-95. PubMed ID: 16309296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.
    Zheng F; Bayram E; Sumithran SP; Ayers JT; Zhan CG; Schmitt JD; Dwoskin LP; Crooks PA
    Bioorg Med Chem; 2006 May; 14(9):3017-37. PubMed ID: 16431111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive models of Cannabinoid-1 receptor antagonists derived from diverse classes.
    Kang NS; Lee GN; Yoo SE
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2990-6. PubMed ID: 19406638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
    Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
    Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-based molecular modeling study on a chemically diverse series of cholecystokinin-B/gastrin receptor antagonists: generation of predictive model.
    Chopra M; Mishra AK
    J Chem Inf Model; 2005; 45(6):1934-42. PubMed ID: 16309300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSARs and activity predicting models for competitive inhibitors of adenosine deaminase.
    Sadat Hayatshahi SH; Abdolmaleki P; Ghiasi M; Safarian S
    FEBS Lett; 2007 Feb; 581(3):506-14. PubMed ID: 17250831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical geometry based prediction of nonsynonymous SNP functional effects using random forest and neuro-fuzzy classifiers.
    Barenboim M; Masso M; Vaisman II; Jamison DC
    Proteins; 2008 Jun; 71(4):1930-9. PubMed ID: 18186470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrazides of clozapine: a new class of D1 dopamine receptor subtype selective antagonists.
    Sasikumar TK; Burnett DA; Zhang H; Smith-Torhan A; Fawzi A; Lachowicz JE
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4543-7. PubMed ID: 16809034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological descriptors in modeling the agonistic activity of human A3 adenosine receptor ligands: the derivatives of 2-chloro-N(6)-substituted-4'-thioadenosine-5'-uronamide.
    Sharma S; Sharma BK; Sharma SK; Singh P; Prabhakar YS
    Eur J Med Chem; 2009 Apr; 44(4):1377-82. PubMed ID: 18973967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.